RE:Good video to watch.Coalie, from the write-up following the videos. Quote::
The Phase Ib NMIBC clinical study, for the first three patients, successfully met its primary and secondary outcome measures of safety and tolerability and pharmacokinetics (movement and exit of drug within tissue), respectively, as determined by an independent Data Safety Monitoring Board (“DSMB”). The Company will report out on the exploratory endpoint of efficacy, when sufficient clinical data has been collected to intelligently report out on this outcome measure. The DSMB has authorized UHN to enroll an additional 6 patients for the second phase of the Phase Ib clinical study to be treated at a therapeutic dose of the light activated drug, TLD-1433, (0.70 mg/cm2), currently in progress.” Roger needs a proof reader, too. Get the two, 'out' removed , not needed and terrible syntax, and do we need the word intelligent in there? Is anyone expecting something different??? Well, with Roger, hmmmm, don't answer that!! :-))
coalbet wrote: theralase.com/.../theralase-releases-annual-and-special-meeting-videos
Theralase Annual and Special Meeting, held at the Company’s corporate office on June 30, 2017 - a few videos available on the website